Green Cross Lab Cell Corporation (144510) — Capital Reinvestment Ratio
Green Cross Lab Cell Corporation (144510) has a Capital Reinvestment Ratio of 13.65x as of June 2026, meaning it reinvests 14% of its operating cash flow (₩208.25 Million) in capital expenditures (₩2.84 Billion). Check 144510 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Green Cross Lab Cell Corporation Capital Reinvestment Ratio (2015–2025)
This chart tracks Green Cross Lab Cell Corporation's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Green Cross Lab Cell Corporation (144510) cash conversion ratio.
Annual Capital Reinvestment Ratio for Green Cross Lab Cell Corporation (2015–2025)
Year-by-year Capital Reinvestment Ratio for Green Cross Lab Cell Corporation from 2015 to 2025. See 144510 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.70x | ₩9.19 Billion | ₩6.47 Billion | ▲ +32.4% |
| 2024 | 0.53x | ₩11.34 Billion | ₩6.03 Billion | ▼ -89.4% |
| 2023 | 5.01x | ₩3.67 Billion | ₩18.40 Billion | ▲ +4713.9% |
| 2022 | 0.10x | ₩66.42 Billion | ₩6.91 Billion | ▼ -77.1% |
| 2021 | 0.45x | ₩23.91 Billion | ₩10.88 Billion | ▼ -13.6% |
| 2020 | 0.53x | ₩9.09 Billion | ₩4.79 Billion | ▼ -97.8% |
| 2019 | 23.96x | ₩223.04 Million | ₩5.34 Billion | ▲ +146.1% |
| 2018 | 9.74x | ₩490.92 Million | ₩4.78 Billion | ▲ +1468.4% |
| 2017 | 0.62x | ₩2.86 Billion | ₩1.78 Billion | ▲ +10.8% |
| 2015 | 0.56x | ₩1.49 Billion | ₩833.86 Million | — |